Acclinate-logo
Talk to Our Team

In the dynamic realm of clinical research our commitment to Diversity, Equity, and Inclusion (DE&I) stands as a cornerstone for positive change. Acclinate, in partnership with Advarra, is excited to present our Trend Report: DE&I in Clinical Research – a comprehensive exploration of where our inclusivity efforts stand today with tangible recommendations for improving representation in the year ahead. 

‍Clinical trials, crucial for medical progress, often grapple with a lack of diverse representation. Recent FDA directives have emphasized the industry's imperative to embrace inclusivity, steering the research landscape toward a more equitable future.‍

Our joint report unveils key findings, from awareness and confidence levels to strategies for diverse enrollment, providing insights into the elements shaping the path towards inclusivity.

Exploring financial dynamics, we delve into the budgetary impact on recruitment and relationship building. As our path to diversity and health equity continues , we present a blueprint for progress, emphasizing the collective responsibility of stakeholders in fostering inclusivity.

Clinical research isn't just about trials; it's about shaping the future of healthcare. Our Trend Report serves as a call to action, urging the industry to address disparities actively and embrace historically excluded populations.

From actionable insights to tangible ideas, join us in charting the course toward positive change.

Download the full report

 

Recent Posts

FDA Updates Diversity Action Plan Guidance: What Sponsors Need to Know
4 Min Read

From the content of Diversity Action Plans to the nuances of submission, implementation, and monitoring for inclusive and representative research, the...

Read More
doctor using laptop computer
3 Min Read

Though the life sciences industry has committed to improving diversity in clinical trials, there’s still work to be done. Childhood asthma is a case i...

Read More
Unpacking the Latest FDA Guidance: Diversity in Clinical Trials for Pharma
3 Min Read

Earlier this year, the U.S. Food and Drug Administration updated its guidance document on collecting race and ethnicity data in clinical trials. The d...

Read More
Clinical Trial Recruitment Strategies that Increase Diversity
3 Min Read

Under 2022’s Food and Drug Omnibus Reform Act, clinical trial sponsors are required tosubmit diversity action plans with pivotal drug studies such as ...

Read More
Using Clinical Trial Services to Connect with Communities of Color
4 Min Read

Clinical research requires trust between the patient and the pharmaceutical companies. When that trust has been damaged, patients will avoid participa...

Read More
Overcome Clinical Trial Recruitment Challenges: Start with Affective Trust
4 Min Read

Inclusive clinical research populations are necessary for a successful study, and new laws are beginning to mandate diversity action plans to promote ...

Read More
Empowering Healthcare Equity: Celebrating 4 Years of Acclinate's Innovation
1 Min Read

As we celebrate our four-year anniversary, Acclinate stands at the forefront of a crucial revolution in healthcare—empowering communities of color to ...

Read More
Marques Bradley: Coding for a Cause at Acclinate
2 Min Read

When Marques Bradley joined Acclinate amidst the pandemic's uncertainty in October of 2020, it wasn't just another job opportunity; it was a call to m...

Read More
The Consequences of a Lack of Diversity in Clinical Trials
3 Min Read

Your clinical research processes are carefully developed over the years, and the success of your project depends on thoughtful preparation. As pharmac...

Read More